Simcere Pharmaceutical Group Limited (HK:2096) has released an update.
Simcere Pharmaceutical Group Limited announced the successful passage of all proposed resolutions during their Annual General Meeting on June 14, 2024, including the adoption of the audited financial statements, re-election of directors, and a final dividend payout of RMB0.16 per share. Shareholders overwhelmingly supported the resolutions, with nearly unanimous votes in favor. The meeting also authorized the reappointment of KPMG as auditors and granted the Directors a mandate to manage the company’s securities.
For further insights into HK:2096 stock, check out TipRanks’ Stock Analysis page.
